Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

DESIGN-ZYME LLC

UEI: RM33XDX5RRG4CAGE: 7KSG8

DESIGN-ZYME LLC is a federal contractor, registered under UEI RM33XDX5RRG4 and CAGE code 7KSG8. It has been awarded $4,778,819 in federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology), Unknown NAICS, and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services and Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

RM33XDX5RRG4

CAGE Code

7KSG8

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

DESIGN-ZYME LLC specializes in the design and development of novel biotechnological adjuvants for next-generation vaccine platforms, with a focused expertise in covalent chemistry applied to polysaccharide-based immunomodulators. Their technical capabilities center on the synthesis and characterizat...

DESIGN-ZYME LLC specializes in the design and development of novel biotechnological adjuvants for next-generation vaccine platforms, with a focused expertise in covalent chemistry applied to polysaccharide-based immunomodulators. Their technical capabilities center on the synthesis and characterization of chemically modified hyaluronic acid derivatives optimized for enhanced antigen presentation and dendritic cell activation, positioning them at the intersection of glycoconjugate chemistry and mucosal immunology. The company applies precise bioconjugation techniques to engineer stable, multivalent vaccine formulations capable of eliciting robust T-cell and humoral responses against complex pathogens like Borrelia burgdorferi, demonstrating deep proficiency in antigen-adjuvant co-formulation, stability profiling, and preclinical immunogenicity assessment. Their differentiation lies in leveraging covalent bonding strategies to overcome the limitations of traditional alum or oil-in-water adjuvants, enabling more targeted and durable immune priming without excessive reactogenicity. The contractor has delivered research and development services exclusively to the Department of Health and Human Services, specifically supporting advanced vaccine development initiatives under public health preparedness mandates. Their engagement reflects a mission-aligned partnership focused on addressing emerging infectious disease threats through innovative immunological engineering. Their primary industry focus is Research and Development in Biotechnology (NAICS 541714), where they operate within the niche of non-nanoparticle-based biologic adjuvants, serving the federal vaccine development ecosystem. This specialization aligns with HHS priorities in Lyme disease prevention and next-generation multivalent vaccine platforms, distinguishing them from broader biotech firms by their chemical precision and focus on carbohydrate-based immunomodulation. DESIGN-ZYME LLC is a small, privately held entity based in Lawrence, Kansas, with no federal certifications on record. Operating as a lean R&D firm, they maintain a focused geographic footprint centered on Kansas but serve national public health objectives through targeted federal contracts. Their market positioning is that of a specialized biotechnology innovator advancing novel adjuvant technologies for federal vaccine programs.

Key Performance Metrics

Awards Count

6

All time

Active

1

Currently performing

Completed

5

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with DESIGN-ZYME LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for DESIGN-ZYME LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in DESIGN-ZYME LLC's top NAICS codes and agencies

NAICS: 541714
New
Federal
High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Solicitation # DARPA-PA-27-01
The High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE) program, solicited by the DARPA Biological Technologies Office under DARPA-PA-27-01, seeks to develop an in-silico capability for mapping all protein-protein interactions. The primary objective is to create a comprehensive human interactome hypercatalog capturing over 10 million new interactions, shifting from static biomarkers to dynamic, context-aware interactomes. The utility of this capability will be demonstrated by identifying novel diagnostic and therapeutic targets for traumatic brain injury. Awards will be issued as Other Transaction (OT) for Research agreements with fixed, payable milestones. The program is structured in two phases, with Phase 1 estimated at 12 months and Phase 2 anticipated at 18 months, though current awards are limited to Phase 1. Proposers, including large and small businesses, universities, and research institutions, must submit a maximum six-page unclassified abstract via the Broad Agency Announcement Tool by November 5, 2026, to be considered for an Oral Proposal Package due December 11, 2026. Evaluation is based on technical comprehension, technical ability, and the realism of the cost rough order of magnitude. Prime proposers must be registered in the System for Award Management and demonstrate CMMC Level 1 compliance. Performance will be managed through a Task Description Document and a milestone-based payment schedule, with invoicing processed through the Wide Area Workflow system. Security requirements include the Fundamental Research Risk-Based Security Review Process for all senior and key personnel.
Defense Advanced Research Projects Agcy

POSTED

about 24 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541330
New
Federal
AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING
Solicitation # FA7037-21-S-C001
The Air Force Cryptologic Office (AFCO) Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and innovative services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. The procurement process is divided into two phases: Phase I requires the submission of a quad chart and a white paper, while Phase II consists of full proposals by invitation only. Awards may be issued as traditional contracts or Other Transactions (OT), with potential funding ranging from 50,000 dollars to 50 million dollars over a period of performance lasting between one and five years. The evaluation process is based on technical merit, importance to agency programs, and fund availability, utilizing peer or scientific review to select offerors. Successful projects are expected to follow a structure of base period tasks to demonstrate feasibility, followed by option tasks for design, fabrication, testing, and evaluation. Because the work supports DoD ISR-Cyber capabilities, offerors must possess the necessary personnel and facility security clearances to handle classified work independently. All acquired technologies are treated as commercial items under 10 USC 3458 and DFARS 212.70. Submissions are managed by Carissa Heuertz, and the performance location is identified as San Antonio, Texas.
Department Of Defense

POSTED

about 24 hours ago

DEADLINE

in 11 months
View Details
NAICS: 541714
New
Federal
RFI Alzheimer’s Research Program (AZRP) Public
Solicitation # HT9427RFI2027AZRP
The Defense Health Agency, through the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027AZRP to gather strategic feedback for the fiscal year 2027 Alzheimer’s Research Program. The primary objective is to identify research focus areas and funding opportunities aimed at mitigating the impact of Alzheimer's and related dementias, specifically those associated with traumatic brain injury, military service, and diverse risks. The program seeks to improve the quality of life for Service Members, Veterans, and their families by funding solution-oriented research, including the development of digital and blood-based biomarkers for early diagnosis and the creation of precision prevention strategies. This action is strictly for information and planning purposes and does not constitute a formal solicitation, request for proposals, or request for quotations. No contracts will be awarded based on this announcement, and FY27 funds have not yet been appropriated. Interested parties from academia, industry, non-profit organizations, and federal agencies are invited to provide feedback via Survey Monkey by December 4, 2026. Respondents are cautioned not to submit proprietary or sensitive information through the survey portal as it cannot be protected. The effort is categorized under NAICS code 541714 and is managed by the Department of Defense in Fort Detrick, Maryland.
Defense Health Agency

POSTED

2 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Traumatic Brain Injury and Psychological Health Research Program Public Request for Information
Solicitation # HT9427RFI2027TBIPHRP
The Defense Health Agency, under the Department of Defense and the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027TBIPHRP. This action is strictly for strategic planning and is not a formal solicitation, request for proposals, or request for quotations. The primary objective is to gather feedback from academia, industry, non-profit organizations, and the public to inform the research focus areas and funding opportunities for the fiscal year 2027 Traumatic Brain Injury and Psychological Health Research Program. The program aims to optimize the prevention, assessment, and treatment of psychological health conditions and traumatic brain injuries to benefit Service Members, Veterans, and the general public. Interested parties are asked to provide input on research gaps and funding priorities, specifically regarding the prevention, screening, diagnosis, and treatment of these conditions. Responses must be submitted via Survey Monkey by December 11, 2026. Because the government cannot protect proprietary or sensitive information submitted through the survey platform, such data should not be included. This inquiry does not commit the program to incorporating the feedback into future funding opportunities, and no contract will be awarded based on this specific announcement. All inquiries regarding this RFI should be directed to Patrick M. Younkins.
Defense Health Agency

POSTED

2 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The objective is to maintain a permanent readiness posture against high-threat influenza and other viruses with pandemic potential. Selected contractors will provide essential services, personnel, and facilities to produce vaccines, antigens, and adjuvants, while generating the necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission to support rapid regulatory decisions. To be eligible, offerors must be capable of producing vaccines against influenza strains with pandemic potential and demonstrate success through a U.S. influenza vaccine license or a submitted Biologics License Application. The government intends to award contracts to four offerors based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology. Evaluation focuses on capabilities, past performance, and price, with a minimum requirement of a High Confidence rating for technical capabilities. The contract structure consists of a 60-month base period and a 60-month option period, with a minimum guarantee of 50,000 dollars. Key requirements include the development of comprehensive manufacturing and business continuity plans, adherence to strict ASPR security and cybersecurity standards, and the use of the Department of Treasury Invoice Processing Platform for quarterly invoicing. Performance is monitored through a BARDA dose tracker, and final acceptance is triggered by the submission of a final report and updated dose tracking data.
Barda - Aspr / Daappo / Barda Dcma

POSTED

3 days ago

DEADLINE

in 22 days
View Details
NAICS: 541714
New
Federal
Quantitative Analysis of Longitudinal MR Images
Solicitation # 75N98027R00005
Solicitation 75N98027R00005 is a Sources Sought notice issued by the National Institute on Aging (NIA) to identify qualified companies capable of performing quantitative analysis of longitudinal Magnetic Resonance (MR) images. The project supports the Baltimore Longitudinal Study of Aging (BLSA) by processing 300 newly acquired MR datasets to characterize brain aging trajectories and identify predictors of cognitive decline and Alzheimer’s disease. The selected contractor will provide specialized, non-commercial services to deliver global and regional tissue volumes, lesion quantification, and machine learning-derived scores, such as SPARE-AD, while ensuring longitudinal consistency with data acquired since 1994. The anticipated contract will be a firm fixed price award with a period of performance of one year. Key deliverables include quantitative volumetric results, intermediate processing files, and registration maps for PET overlay, submitted every six months, concluding with a final report. Technical requirements emphasize the use of established image analysis tools and adherence to FISMA/FedRAMP-aligned data security controls to protect participant confidentiality. Interested respondents must submit a capability statement by November 9, 2026, to Contract Specialist Sneha Singh. The submission must be limited to ten pages and include the company's Unique Entity ID, NAICS code 541714, professional qualifications of personnel, and any applicable GSA schedules or government-wide acquisition contracts. Small businesses are encouraged to respond to this market research effort to help the government determine the appropriate acquisition method.
National Institutes Of Health Olao

POSTED

6 days ago

DEADLINE

in 11 days
View Details